Results 251 to 260 of about 777,469 (303)
Some of the next articles are maybe not open access.
New England Journal of Medicine, 2004
The story of the first implantation of a permanent artificial heart and the blizzard of reaction.
openaire +2 more sources
The story of the first implantation of a permanent artificial heart and the blizzard of reaction.
openaire +2 more sources
1990
The first attempt to utilize a total artificial heart (TAH) was by Demikhov (Figure 33.1), who removed a dog’s heart and replaced it with a mechanical device1. His original plan was to maintain an artificial circulation, so that the organs from a cadaver could be used for transplantation1.
E. Solis, MUNERETTO, Claudio, C. Cabrol
openaire +2 more sources
The first attempt to utilize a total artificial heart (TAH) was by Demikhov (Figure 33.1), who removed a dog’s heart and replaced it with a mechanical device1. His original plan was to maintain an artificial circulation, so that the organs from a cadaver could be used for transplantation1.
E. Solis, MUNERETTO, Claudio, C. Cabrol
openaire +2 more sources
Surgical Technology Online, 2021
The SynCardia Total Artificial Heart (TAH, SynCardia Systems, Tucson, AZ) is the only biventricular cardiac replacement approved for bridge to transplantation by the U.S. Food and Drug Administration (FDA) and which carries the European Union CE mark. It has been implanted in about 2000 patients. In experienced centers, 60 to 80 % of implanted patients
Jack, Copeland +4 more
openaire +2 more sources
The SynCardia Total Artificial Heart (TAH, SynCardia Systems, Tucson, AZ) is the only biventricular cardiac replacement approved for bridge to transplantation by the U.S. Food and Drug Administration (FDA) and which carries the European Union CE mark. It has been implanted in about 2000 patients. In experienced centers, 60 to 80 % of implanted patients
Jack, Copeland +4 more
openaire +2 more sources
Polish artificial heart program
WIREs Nanomedicine and Nanobiotechnology, 2011AbstractDespite significant advances in the development of artificial heart substitutes, anthrombogenic materials and surfaces remain to be the main challenge for implants, which can prevent thrombosis that leads to rejection. The goal of material engineering is essentially to design polymeric materials of high durability and optimal thrombogenicity in
Miroslawa, El Fray, Monika, Czugala
openaire +2 more sources
Experimental artificial heart implantation
The American Journal of Surgery, 1963Abstract 1. 1. An artificial heart with external compression power and control of our own design has been described. 2. 2. Experience with twenty-one implantations in dogs is discussed with special reference to causes of failure. Loss of valve fixation and compressor breakdown accounted for most of the failures. 3. 3. At autopsy, clot was
W G, RAINER +3 more
openaire +2 more sources
Total Artificial Heart Implantation
Archives of General Psychiatry, 1984This report details the implantation of a total artificial heart into a human being who survived for 112 days. Included are the criteria for candidate selection, the preoperative psychiatric evaluation, and the description of operative and postoperative complications in the context of the research subject's mental status over the period of his survival.
C K, Berenson, B I, Grosser
openaire +2 more sources
Nature Medicine, 2003
Over the past 50 years, significant advances have been made in the development of total artificial hearts (TAH). These advances have most recently led to a clinical trial of a unique, transcutaneously powered TAH.
openaire +2 more sources
Over the past 50 years, significant advances have been made in the development of total artificial hearts (TAH). These advances have most recently led to a clinical trial of a unique, transcutaneously powered TAH.
openaire +2 more sources
Kyobu geka. The Japanese journal of thoracic surgery, 2007
Artificial heart or heart transplantation are required for the treatment of profound heart failure. Total artificial heart (TAH) and ventricular assist system (VAS) were developed from late 1950s and 2 extracorporeal pneumatic Japanese VASs (Toyobo VAS and Zeon VAS) were introduced to clinical field from 1980.
openaire +1 more source
Artificial heart or heart transplantation are required for the treatment of profound heart failure. Total artificial heart (TAH) and ventricular assist system (VAS) were developed from late 1950s and 2 extracorporeal pneumatic Japanese VASs (Toyobo VAS and Zeon VAS) were introduced to clinical field from 1980.
openaire +1 more source
AACN Advanced Critical Care, 1991
In the early 1800s, an awareness of potential ventricular failure stimulated interest in artificial heart replacement. In 1937 the first total artificial heart (TAH) was implanted into the chest of a dog by Russian physicians. The primary driving force for mechanical cardiac assistance developed from the necessity for circulatory assistance in order to
openaire +2 more sources
In the early 1800s, an awareness of potential ventricular failure stimulated interest in artificial heart replacement. In 1937 the first total artificial heart (TAH) was implanted into the chest of a dog by Russian physicians. The primary driving force for mechanical cardiac assistance developed from the necessity for circulatory assistance in order to
openaire +2 more sources